SARS-COV-2 Viral Budding and Entry can be Modeled Using BSL-2 Level Virus-Like Particles

被引：0
|
作者：
Plescia, Caroline
David, Emily
Patra, Dhabaleswar
Sengupta, Ranjan
Amiar, Souad
Su, Yuan
Stahelin, Robert
机构：
来源：
FASEB JOURNAL | 2021年 / 35卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1096/fasebj.2021.35.S1.03012
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
    Yasaman Behzadipour
    Shiva Hemmati
    International Journal of Peptide Research and Therapeutics, 2022, 28
  • [42] Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
    Behzadipour, Yasaman
    Hemmati, Shiva
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2022, 28 (01)
  • [43] Sequential Immunization with Vaccines Based on SARS-CoV-2 Virus-like Particles Induces Broadly Neutralizing Antibodies
    Mi, Youjun
    Xu, Kun
    Wang, Wenting
    Kong, Weize
    Xu, Xiaonan
    Rong, Xifeng
    Tan, Jiying
    VACCINES, 2024, 12 (08)
  • [44] Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System (vol 8, 862, 2020)
    Xu, Ruodan
    Shi, Mingfei
    Li, Jing
    Song, Ping
    Li, Ning
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [45] Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Sulbaran, Guidenn
    Maisonnasse, Pauline
    Amen, Axelle
    Effantin, Gregory
    Guilligay, Delphine
    Dereuddre-Bosquet, Nathalie
    Burger, Judith A.
    Poniman, Meliawati
    Grobben, Marloes
    Buisson, Marlyse
    Dylon, Sebastian Dergan
    Naninck, Thibaut
    Lemai, Julien
    Gros, Wesley
    Gallouet, Anne-Sophie
    Marlin, Romain
    Bouillier, Camille
    Contreras, Vanessa
    Relouzat, Francis
    Fenel, Daphna
    Thepaut, Michel
    Bally, Isabelle
    Thielens, Nicole
    Fieschi, Franck
    Schoehn, Guy
    van der Werf, Sylvie
    van Gils, Marit J.
    Sanders, Rogier W.
    Poignard, Pascal
    Le Grand, Roger
    Weissenhorn, Winfried
    CELL REPORTS MEDICINE, 2022, 3 (02)
  • [46] Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
    Edeling, Melissa A.
    Earnest, Linda
    Montoya, Julio Carrera
    Yap, Ashley Huey Yiing
    Mumford, Jamie
    Roberts, Jason
    Wong, Chinn Yi
    Hans, Dhiraj
    Grima, Joseph
    Bisset, Nicole
    Bodle, Jesse
    Rockman, Steven
    Torresi, Joseph
    BIOTECHNOLOGY AND BIOENGINEERING, 2025,
  • [47] Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2
    Liu, Shuo
    Zhang, Li
    Fu, Wangjun
    Liang, Ziteng
    Yu, Yuanling
    Li, Tao
    Tong, Jincheng
    Liu, Fan
    Nie, Jianhui
    Lu, Qiong
    Lu, Shuaiyao
    Huang, Weijin
    Wang, Youchun
    MEDCOMM, 2024, 5 (06):
  • [48] Identification of Botanical Viral Entry Inhibitors for SARS-CoV-2
    Risener, Caitlin J.
    Woo, Sunmin
    Samarakoon, Tharamangala
    Caputo, Marco
    Edwards, Emily
    Zandi, Keivan
    Goh, Shu Ling
    Downs-Bowen, Jessica A.
    FASEB JOURNAL, 2022, 36
  • [49] SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests
    Roessler, Johannes
    Pich, Dagmar
    Kraehling, Verena
    Becker, Stephan
    Keppler, Oliver T.
    Zeidler, Reinhard
    Hammerschmidt, Wolfgang
    BIOMEDICINES, 2023, 11 (11)
  • [50] Structural stability of SARS-CoV-2 virus like particles degrades with temperature
    Sharma, A.
    Preece, B.
    Swann, H.
    Fan, X.
    McKenney, R. J.
    Ori-McKenney, K. M.
    Saffarian, S.
    Vershinin, M. D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 : 343 - 346
12345